Atom Grants
Discover
  • Dashboard
  • Search
  • Deep Research
  • Favorites
  • Projects

    Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed)

    This grant supports researchers in analyzing existing data to understand cancer risk and related outcomes, aiming to address key scientific questions in cancer research.

    Browse similar grants
    Cancer Research Grants 2026
    OverviewSimilar Grants
    OverviewSimilar Grants

    Research Opportunities in Cancer Epidemiology Cohort Studies (U01 Clinical Trial Not Allowed)

    The National Cancer Institute funds cancer epidemiology cohort research on cancer causes and survivorship, including cohort upkeep, follow-up, and data and biospecimen sharing; clinical trials are not allowed.

    HHS-NIH11Due Feb 5, 2027

    Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required)

    This grant supports investigator-initiated clinical trials to reduce cancer burden through early detection, prevention, and survivorship improvements.

    HHS-NIH11Due Jan 7, 2027

    Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)

    This grant funds projects to further develop and validate innovative technologies that advance cancer research or clinical care, focusing on technical improvements and rigorous validation for broad adoption.

    HHS-NIH11Forecasted Jun 4, 2027$300,000Forecasted

    Modular R01s in Cancer Control and Population Sciences (R01 Clinical Trial Optional)

    Funding opportunity for cancer research innovations in statistical methods, epidemiology, survivorship, behaviors, healthcare, and implementation.

    HHS-NIH11Due Feb 5, 2027$1,250,000

    Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)

    This grant funds early-stage, highly innovative technology development projects to improve cancer research or clinical care, focusing on proof-of-concept studies with high potential impact in cancer-related fields.

    HHS-NIH11Forecasted Jun 4, 2027$150,000Forecasted